Brain and lesion segmentation in multiple sclerosis using fully convolutional neural networks: A large-scale study.

Autor: Gabr RE; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Coronado I; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Robinson M; Department of Electrical Engineering, The University of Texas at Tyler, Houston, TX, USA., Sujit SJ; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Datta S; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Sun X; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Allen WJ; Texas Advanced Computing Center, The University of Texas at Austin, Austin, TX, USA., Lublin FD; Mount Sinai Medical Center, New York, NY, USA., Wolinsky JS; Department of Neurology, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Narayana PA; Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Jazyk: angličtina
Zdroj: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2020 Sep; Vol. 26 (10), pp. 1217-1226. Date of Electronic Publication: 2019 Jun 13.
DOI: 10.1177/1352458519856843
Abstrakt: Objective: To investigate the performance of deep learning (DL) based on fully convolutional neural network (FCNN) in segmenting brain tissues in a large cohort of multiple sclerosis (MS) patients.
Methods: We developed a FCNN model to segment brain tissues, including T2-hyperintense MS lesions. The training, validation, and testing of FCNN were based on ~1000 magnetic resonance imaging (MRI) datasets acquired on relapsing-remitting MS patients, as a part of a phase 3 randomized clinical trial. Multimodal MRI data (dual-echo, FLAIR, and T1-weighted images) served as input to the network. Expert validated segmentation was used as the target for training the FCNN. We cross-validated our results using the leave-one-center-out approach.
Results: We observed a high average (95% confidence limits) Dice similarity coefficient for all the segmented tissues: 0.95 (0.92-0.98) for white matter, 0.96 (0.93-0.98) for gray matter, 0.99 (0.98-0.99) for cerebrospinal fluid, and 0.82 (0.63-1.0) for T2 lesions. High correlations between the DL segmented tissue volumes and ground truth were observed ( R 2  > 0.92 for all tissues). The cross validation showed consistent results across the centers for all tissues.
Conclusion: The results from this large-scale study suggest that deep FCNN can automatically segment MS brain tissues, including lesions, with high accuracy.
Databáze: MEDLINE